Literature DB >> 10770843

Matrix metalloproteinase-3 removes agrin from synaptic basal lamina.

M VanSaun1, M J Werle.   

Abstract

Agrin, a heparin sulfate proteoglycan, is an integral member of the synaptic basal lamina and plays a critical role in the formation and maintenance of the neuromuscular junction. The N-terminal region of agrin binds tightly to basal lamina, while the C-terminal region interacts with a muscle-specific tyrosine kinase (MuSK) to induce the formation of the postsynaptic apparatus. Although the binding of agrin to basal lamina is tight, the binding of agrin to MuSK has yet to be shown; therefore, basal lamina binding is critical for maintaining the presentation of agrin to MuSK. Here we report evidence that supports our hypothesis that matrix metalloproteinase-3 (MMP-3) is responsible for the removal of agrin from synaptic basal lamina. Antibodies to the hinge region of human MMP-3 recognize molecules concentrated at the frog neuromuscular junction in both cross sections and whole mounts. Electron microscopy of neuromuscular junctions stained with antibodies to MMP-3 reveals that staining is found in the extracellular matrix surrounding the Schwann cell. Treatment of sections from frog anterior tibialis muscle with MMP-3 results in a clear and reproducible removal of agrin immunoreactivity from synaptic basal lamina. The same MMP-3 treatment does not alter anti-laminin staining. These results support our hypothesis that synaptic activity results in the activation of MMP-3 at the neuromuscular junction and that MMP-3 specifically removes agrin from synaptic basal lamina. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10770843

Source DB:  PubMed          Journal:  J Neurobiol        ISSN: 0022-3034


  18 in total

1.  Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits.

Authors:  Diane M Jaworski; Paul Soloway; John Caterina; William A Falls
Journal:  J Neurobiol       Date:  2006-01

2.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates neuromuscular junction development via a beta1 integrin-mediated mechanism.

Authors:  Gentian Lluri; Garret D Langlois; Brian McClellan; Paul D Soloway; Diane M Jaworski
Journal:  J Neurobiol       Date:  2006-10

3.  Role of pro-brain-derived neurotrophic factor (proBDNF) to mature BDNF conversion in activity-dependent competition at developing neuromuscular synapses.

Authors:  H Shawn Je; Feng Yang; Yuanyuan Ji; Guhan Nagappan; Barbara L Hempstead; Bai Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

4.  Immunoscreening of the extracellular proteome of colorectal cancer cells.

Authors:  Susanne Klein-Scory; Salwa Kübler; Hanna Diehl; Christina Eilert-Micus; Anke Reinacher-Schick; Kai Stühler; Bettina Warscheid; Helmut E Meyer; Wolff Schmiegel; Irmgard Schwarte-Waldhoff
Journal:  BMC Cancer       Date:  2010-02-25       Impact factor: 4.430

Review 5.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

6.  Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins.

Authors:  Sara Monea; Bryen A Jordan; Sapna Srivastava; Sunita DeSouza; Edward B Ziff
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

7.  Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.

Authors:  Georgina S Butler; Richard A Dean; Eric M Tam; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

8.  Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation.

Authors:  K Conant; Y Wang; A Szklarczyk; A Dudak; M P Mattson; S T Lim
Journal:  Neuroscience       Date:  2010-01-04       Impact factor: 3.590

9.  Site-directed MT1-MMP trafficking and surface insertion regulate AChR clustering and remodeling at developing NMJs.

Authors:  Zora Chui-Kuen Chan; Hiu-Lam Rachel Kwan; Yin Shun Wong; Zhixin Jiang; Zhongjun Zhou; Kin Wai Tam; Ying-Shing Chan; Chi Bun Chan; Chi Wai Lee
Journal:  Elife       Date:  2020-03-24       Impact factor: 8.140

10.  Pro-BDNF-induced synaptic depression and retraction at developing neuromuscular synapses.

Authors:  Feng Yang; Hyun-Soo Je; Yuanyuan Ji; Guhan Nagappan; Barbara Hempstead; Bai Lu
Journal:  J Cell Biol       Date:  2009-05-18       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.